ARCHIVE

• PRESS SEMINAR
  April 5, 2004

• NHI Prices of 35 Unprofitable Products to Be Raised in April
  March 29, 2004

• BUSINESS NEWS IN BRIEF
  March 29, 2004

• Drug Makers Need Research Tools from Universities: JPMA Symposium
  March 29, 2004

• Merck Ltd to Focus on Cancer, Emergency Care
  March 29, 2004

• Leading Makers to Obtain Evidence on Their Defensive Factor-enhancing Anti-Ulcer Drugs
  March 29, 2004

• 4 Potential Blockbusters in the Pipeline: Eisai
  March 29, 2004

• GSK to Strengthen Promotion of Serevent for COPD
  March 29, 2004

• Aiming to Be a Global Research-driven Company Based in Japan: Dr Takenaka of Yamanouchi
  March 29, 2004

• DIAGNOSTIC NEWS IN BRIEF
  March 29, 2004

• Takeda's Income from IP to Exceed \60 Bil. in FY2003
  March 29, 2004

• WORLD NEWS IN BRIEF
  March 29, 2004

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  March 29, 2004

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  March 29, 2004

• American College of Cardiology 53rd Annual Scientific Session
  March 29, 2004

• Outsources of Hospital Services Increasing: JHEF Survey
  March 29, 2004

• OTC NEWS IN BRIEF
  March 29, 2004

• OBITUARY
  March 29, 2004

• Switch to GE Injectables to Save \200 Mil. Annually: St. Marianna Univ. Hospital
  March 29, 2004

• Clinical Oncologist Certification System to Be Established
  March 29, 2004

ページ

• « 先頭
• ‹ Prev
• …
• 539
• 540
• 541
• 542
• 543
• 544
• 545
• 546
• 547
• …
• Next ›
• 最終 »